Treatment Section 1 Management of the psychoses 2 The antipsychotics 3 Antipsychotic side effects and their management References Section 2 Management of depression 4 The antidepressants 5 Side effects of antidepressants References Section 3 Management of bipolar disorders 6 Management of acute bipolar disorder 7 Mood-stabilisers References Section 4 Stimulants & Drugs for children 8 Stimulants & Drugs for children References Section 5 Management of anxiety 8 The anxiety disorders 10 Benzodiazepine anxiolytics 11 Anxiolysis and the serotonin system 12 Beta-blockers and anxiety References Section 6 Management of sleep disorders and insomnia 13 Sleep disorders and insomnia 14 Non-pharmacological management of insomnia 15 Hypnotics 16 Sedatives References Section 7 Management of cognitive impairment 17 Cognitive enhancement and the dementias 18 Cognitive enhancement and neuroprotection References Section 8 Management of sexual difficulties 19 The range of sexual difficulties 20 Effects of drugs on aspects of sexual functioning Appendix 20.1 Male sexual functioning questionnaire Appendix 20.2 Female sexual functioning questionnaire References Section 9 Management of dependence and withdrawal 21 Dependence & Withdrawal 22 Dependence & Craving 23 Dependence & Protracted Withdrawal References Section 10 Consent, abuse and liability 24 Consent 25 Pharmacological abuse References Section 11 The marketing of tranquillity 26 The ethical industry 27 Evidence-biased care 28 Marketing & Risk 29 From healthcare to pharmageddon
A professor of Psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology, and has authored more than 200 peer-reviewed articles, 200 other pieces, and 20 books, including The Antidepressant Era and The Creation of Psychopharmacology from Harvard University Press, The Psychopharmacologists Volumes 1-3 and Let Them Eat Prozac from New York University Press, and Mania from Johns Hopkins University Press. David's latest book, Pharmageddon, documents the riveting and terrifying story of how pharmaceutical companies have hijacked healthcare in America and the life-threatening results. David's main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture.